TinderMIX: Time-dose integrated modelling of toxicogenomics data.
BMD
MOA
dose-response
dynamic dose-dependent
gene expression
integrated modeling
mechanism of action
time course
toxicogenomics
Journal
GigaScience
ISSN: 2047-217X
Titre abrégé: Gigascience
Pays: United States
ID NLM: 101596872
Informations de publication
Date de publication:
01 05 2020
01 05 2020
Historique:
received:
27
02
2020
revised:
22
04
2020
accepted:
05
05
2020
entrez:
26
5
2020
pubmed:
26
5
2020
medline:
5
10
2021
Statut:
ppublish
Résumé
Omics technologies have been widely applied in toxicology studies to investigate the effects of different substances on exposed biological systems. A classical toxicogenomic study consists in testing the effects of a compound at different dose levels and different time points. The main challenge consists in identifying the gene alteration patterns that are correlated to doses and time points. The majority of existing methods for toxicogenomics data analysis allow the study of the molecular alteration after the exposure (or treatment) at each time point individually. However, this kind of analysis cannot identify dynamic (time-dependent) events of dose responsiveness. We propose TinderMIX, an approach that simultaneously models the effects of time and dose on the transcriptome to investigate the course of molecular alterations exerted in response to the exposure. Starting from gene log fold-change, TinderMIX fits different integrated time and dose models to each gene, selects the optimal one, and computes its time and dose effect map; then a user-selected threshold is applied to identify the responsive area on each map and verify whether the gene shows a dynamic (time-dependent) and dose-dependent response; eventually, responsive genes are labelled according to the integrated time and dose point of departure. To showcase the TinderMIX method, we analysed 2 drugs from the Open TG-GATEs dataset, namely, cyclosporin A and thioacetamide. We first identified the dynamic dose-dependent mechanism of action of each drug and compared them. Our analysis highlights that different time- and dose-integrated point of departure recapitulates the toxicity potential of the compounds as well as their dynamic dose-dependent mechanism of action.
Sections du résumé
BACKGROUND
Omics technologies have been widely applied in toxicology studies to investigate the effects of different substances on exposed biological systems. A classical toxicogenomic study consists in testing the effects of a compound at different dose levels and different time points. The main challenge consists in identifying the gene alteration patterns that are correlated to doses and time points. The majority of existing methods for toxicogenomics data analysis allow the study of the molecular alteration after the exposure (or treatment) at each time point individually. However, this kind of analysis cannot identify dynamic (time-dependent) events of dose responsiveness.
RESULTS
We propose TinderMIX, an approach that simultaneously models the effects of time and dose on the transcriptome to investigate the course of molecular alterations exerted in response to the exposure. Starting from gene log fold-change, TinderMIX fits different integrated time and dose models to each gene, selects the optimal one, and computes its time and dose effect map; then a user-selected threshold is applied to identify the responsive area on each map and verify whether the gene shows a dynamic (time-dependent) and dose-dependent response; eventually, responsive genes are labelled according to the integrated time and dose point of departure.
CONCLUSIONS
To showcase the TinderMIX method, we analysed 2 drugs from the Open TG-GATEs dataset, namely, cyclosporin A and thioacetamide. We first identified the dynamic dose-dependent mechanism of action of each drug and compared them. Our analysis highlights that different time- and dose-integrated point of departure recapitulates the toxicity potential of the compounds as well as their dynamic dose-dependent mechanism of action.
Identifiants
pubmed: 32449777
pii: 5843735
doi: 10.1093/gigascience/giaa055
pmc: PMC7247400
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press.
Références
Regul Toxicol Pharmacol. 2005 Aug;42(3):265-74
pubmed: 15979222
J Proteomics. 2011 Nov 18;74(12):2691-702
pubmed: 21609791
J Appl Toxicol. 2016 Aug;36(8):1048-59
pubmed: 26671443
Nucleic Acids Res. 2003 Feb 15;31(4):e15
pubmed: 12582260
Sci Rep. 2019 Nov 25;9(1):17497
pubmed: 31767905
Bioinformatics. 2014 Sep 15;30(18):2598-602
pubmed: 24894503
Mutat Res. 2002 Jan 29;499(1):13-25
pubmed: 11804602
Nutr Diabetes. 2016 May 23;6:e210
pubmed: 27214654
Transplant Proc. 1992 Oct;24(5):1663-8
pubmed: 1412789
Gigascience. 2019 Jun 1;8(6):
pubmed: 31140561
Immunopharmacology. 2000 May;47(2-3):119-25
pubmed: 10878286
BMC Genomics. 2007 Oct 25;8:387
pubmed: 17961223
Bioinformatics. 2020 May 1;36(9):2932-2933
pubmed: 31950985
Toxicol Sci. 2007 Jul;98(1):240-8
pubmed: 17449896
Nucleic Acids Res. 2015 Jan;43(Database issue):D921-7
pubmed: 25313160
Toxicol Appl Pharmacol. 2019 Sep 1;378:114634
pubmed: 31226361
BMC Bioinformatics. 2019 Feb 15;20(1):79
pubmed: 30767762
Source Code Biol Med. 2019 Jan 29;14:1
pubmed: 30728855
BMC Bioinformatics. 2017 Jan 14;18(1):33
pubmed: 28088176
Environ Health Perspect. 2006 Jan;114(1):4-9
pubmed: 16393650
Nat Biotechnol. 2010 Aug;28(8):827-38
pubmed: 20676074
Front Pharmacol. 2018 Nov 06;9:1272
pubmed: 30459623
Part Fibre Toxicol. 2016 Mar 15;13:15
pubmed: 26979667
J Biosci Bioeng. 2010 Nov;110(5):511-22
pubmed: 20624688
Nucleic Acids Res. 2017 Jan 4;45(D1):D972-D978
pubmed: 27651457